| Asset | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Equity | 98.03% | 97.41% | 97.26% | 95.92% | 95.81% | 96.90% |
| Debt | 2.55% | 3.65% | 2.88% | 4.52% | 3.25% | 2.11% |
| Others (incl. cash) | -0.58% | -1.06% | -0.14% | -0.44% | 0.94% | 0.99% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 2,25,000 | 41.91 | 7.58% | -1.51%↓ |
| Lupin Ltd. | Healthcare | 1,50,000 | 36.29 | 6.56% | 0.73%↑ |
| Laurus Labs Ltd. | Healthcare | 2,30,000 | 34.9 | 6.31% | 0.55%↑ |
| Ipca Laboratories Ltd. | Healthcare | 1,88,750 | 32.11 | 5.80% | 0.62%↑ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 65,000 | 30.03 | 5.43% | 0.16%↑ |
| Divis Laboratories Ltd. | Healthcare | 45,000 | 29.61 | 5.35% | 1.67%↑ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 31,000 | 26.91 | 4.87% | 0.21%↑ |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | 1,10,000 | 25.25 | 4.57% | 0.19%↑ |
| Fortis Healthcare Ltd. | Healthcare | 2,50,000 | 23.92 | 4.32% | 0.05%↑ |
| Astrazeneca Pharma India Ltd. | Healthcare | 26,000 | 21.39 | 3.87% | -0.25%↓ |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1,08,535 | 19.93 | 3.60% | 0.22%↑ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 80,000 | 17.63 | 3.19% | 0.58%↑ |
| SBI Life Insurance Company Ltd. | Insurance | 1,00,000 | 17.66 | 3.19% | -0.17%↓ |
| Mankind Pharma Ltd. | Healthcare | 65,000 | 16.55 | 2.99% | 2.96%↑ |
| Aurobindo Pharma Ltd. | Healthcare | 1,00,000 | 15.79 | 2.85% | 0.23%↑ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 85,000 | 13.99 | 2.53% | 0.02%↑ |
| Zydus Lifesciences Ltd. | Healthcare | 1,25,000 | 13.91 | 2.51% | 0.53%↑ |
| Aster DM Healthcare Ltd. | Healthcare | 1,70,000 | 13.34 | 2.41% | -0.74%↓ |
| Acutaas Chemicals Ltd. | Healthcare | 36,040 | 12.71 | 2.30% | 0.23%↑ |
| Max Financial Services Ltd. | Financial | 78,498 | 12.43 | 2.25% | 1.03%↑ |
| Sector | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 91.07% | 88.60% | 88.41% | 88.31% | 87.74% | 91.82% |
| Insurance | 3.19% | 6.05% | 6.24% | 6.32% | 6.97% | 3.94% |
| Financial | 2.25% | 1.22% | 1.05% | - | - | - |
| Services | 1.52% | 1.54% | 1.56% | 1.29% | 1.10% | 1.14% |
25.0 / 100
Weighted average Value score is 25.0. This indicates that portfolio is relatively overvalued using composite of value measures.
74.6 / 100
Weighted average Price Momentum score is 74.6. This indicates that portfolio has average momentum using composite of momentum measures.
85.6 / 100
Weighted average Quality score is 85.6. This indicates that portfolio has high quality using composite of quality measures.
71.1 / 100
Weighted average QVM score is 71.1. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
